Story
Shutterstock Shares Fall Following Chief Accounting Officer's Resignation

Summary
Shutterstock Inc. stock fell nearly 8% on Thursday after the company disclosed that Chief Accounting Officer Steven Ciardiello plans to resign. The executive departure overshadowed the recent launch of a new unlimited subscription service.
Shares of Shutterstock, Inc. (NYSE:SSTK) fell sharply on Thursday after the company announced the upcoming resignation of its Chief Accounting Officer, Steven Ciardiello. The stock closed down 7.7% for the session, reflecting investor concern over the departure of a key financial executive.
Executive Departure Details
Shutterstock disclosed that Ciardiello notified the company on July 16, 2026, of his decision to step down. His resignation will be effective August 28, 2026, following a transition period.
The company stated that Ciardiello's decision was not the result of any disagreement with Shutterstock regarding its operations, policies, or practices. A search for a successor is now underway.
AdMarket Context
The negative market reaction to the executive news overshadowed a recent positive announcement from the company. On Tuesday, Shutterstock rolled out the global availability of its Unlimited downloads subscription, a service previously in a beta testing phase.
The new offering includes two plans, Unlimited Images and Unlimited Plus, which provide subscribers with access to over 100 million creative assets, including images, video, and music, alongside AI-powered content generation tools. "Today’s creators need more than access to content," said Paul Teall, Vice President of Marketplace Strategy at Shutterstock. "They need the flexibility to experiment, iterate and produce work at the speed modern marketing demands."
Read next
More on Stocks
Asia and Europe Tipped for Equity Market Leadership Over Next 12 Months
Market analysis suggests Asia ex-Japan offers the highest growth potential, albeit with significant risk, while European equities present a compelling value opportunity as investors look beyond U.S. mega-caps.

aTyr Pharma Shares Surge on FDA Agreement for Pivotal Efzofitimod Trial
Shares of the biopharmaceutical company jumped after it announced an agreement with the U.S. FDA on the design of a Phase 3 study for its lead drug candidate, efzofitimod, in patients with pulmonary sarcoidosis.

Bernstein Taps Amphenol, TE Connectivity as Top Picks for Data Center Growth
Analysts at Bernstein have identified Amphenol and TE Connectivity as leading stocks in the interconnect sector, poised to benefit from the ongoing expansion of data center infrastructure.

AMD Stock Slides From 52-Week High on Summit Disappointment, Analyst Downgrade
Shares of Advanced Micro Devices fell in pre-market trading, pulling back from a recent high as investor hopes for eased U.S.-China tech tensions faded and a recent analyst downgrade cited valuation concerns.